Mouse IFNA13 / Interferon alpha-13 Protein (His Tag)

RP23-139P14.1

Catalog Number	P50670-M08H
Organism Species	Mouse
Host	Human Cells
Synonyms	RP23-139P14.1
Molecular Weight	The recombinant mouse IFNA13 comprises 177 amino acids and has a predicted molecular mass of 20.5 kDa. The apparent molecular mass of the protein is approximately 26-31 kDa in SDS-PAGE under reducing conditions.
predicted N	Cys 24
SDS-PAGE
Purity	> 90 % as determined by SDS-PAGE
Protein Construction	A DNA sequence encoding the mouse IFNA13 (Q80SU4) (Met1-Glu189) was expressed with a C-terminal polyhistidine tag.
Bio-activity	Measured in antiviral assay using L929 cells infected with vesicular stomatitisvirus (VSV). The ED₅₀ for this effect is typically 10-80 pg/mL.
Research Area	Cardiovascular \|Angiogenesis \|Cytokines / Chemokines in Angiogenesis \|Interferons
Formulation	Lyophilized from sterile PBS, pH 7.4. 1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
Background
Reference	Mahmutovic S, et al.. (2004) Significance of the interferon (IFN) in the therapy. Bosn J Basic Med Sci. 4(4): 42-4. Wang, et al.. (2004) Fever of recombinant human interferon-alpha is mediated by opioid domain interaction with opioid receptor inducing prostaglandin E2. J Neuroimmunol. 156(1-2): 107-12.